R1
R2
O
O
O
134.43, 135.85, 137.44, 161.17, 182.17; m/z 236 (M+); Calc. for C16H12O2:
C, 81.34; H, 5.12. Found: C, 81.45; H, 5.12%.
OMe
OMe HO
¶ The reaction of methyl (2Z)-2-bromomethylhex-2-enoate 5g with phenol
in the presence of K2CO3 also provided ca. 15% of a side product,
presumably methyl 2-methylene-3-phenoxyhexanoate (SN2A product).
However, the major compound methyl (2E)-2-phenoxymethylhex-2-enoate
6g was obtained in pure form after silica gel column chromatography (3%
EtOAc–hexane).
R1
i
MeO
MeO
Br
5f
R2
9 R1 = H, R2 = OMe (60%)
10 R1 = OMe, R2 = H (52%)
∑ The (Z)-stereochemistry of the molecules 5 and the (E)-stereochemistry of
ii
1
the molecules 6 and 7 were confirmed by H NMR spectral analysis. It is
well documented in the literature that in the 1H NMR spectrum the chemical
shifts of the vinylic b-proton cis to the ketone, ester and acid carbonyl
groups and of the corresponding vinylic trans b-proton are well-
differentiated and vinylic cis b-protons appear downfield in comparison
with trans protons (ref. 20). The (Z)-stereochemistry of the allyl bromides
5 was assigned on the basis of the chemical shift values of the b-vinylic
protons, i.e. d 7.78–7.91 (when R = Ar) and 6.97 (when R = Pr) (refs. 18,
21). The (E)-stereochemistry of the molecules 6, 7 and 9–12 was assigned
on the basis of the chemical shift values of the b-vinylic protons, i.e. d
8.02–8.25 (when R = Ar) and 6.93–7.11 (when R = Pr) (refs. 18, 22).
** It is well established that in the 1H NMR spectra of 3-benzylidene-
chroman-4-ones the vinylic b- proton cis to the carbonyl group appears at d
ca. 7.7 (refs. 4, 23) while the corresponding trans b-proton appears at d ca.
6.7 (ref. 4). In the case of compounds 4, 8a–f and 13 the vinylic b-protons
appear at d 7.81–7.96. Hence (E)-stereochemistry was assigned to the
compounds 4, 8a–f and 13. In the case of butylidenechroman-4-one 8g (R
= Pr) the vinylic b-proton appears at d 7.04. Therefore (E)-stereochemistry
was assigned to 8g.
O
O
O
R1
R2
iii
OH
R1
MeO
MeO
O
13 R1 = H, R2 = OMe (76%)
(Bonducellin methyl ether)
R2
11 R1 = H, R2 = OMe (94%)
12 R1 = OMe, R2 = H (92%)
4 R1 = OMe, R2 = H (81%)
(Antifungal agent)
Scheme 2 Reagents and conditions: i, K2CO3, acetone, reflux, 3 h; ii, KOH,
H2O, acetone, room temp., 14 h; iii, TFAA, CH2Cl2, reflux, 1 h
bromide 5a‡ with phenol followed by hydrolysis, as a substrate
having a benzylidene moiety. Treatment of 7a with TFAA in
CH2Cl2 provided the desired (E)-3-benzylidenechroman-4-one
8a§ in 91% yield. Encouraged by this success we prepared a
representative class of (E)-3-benzylidenechroman-4-ones 8b–f
using (2E)-3-aryl-2-phenoxymethylprop-2-enoic acids 7b–f
obtained from methyl 3-aryl-3-hydroxy-2-methylenepropa-
noates (Scheme 1, Table 1). With a view to the generalization of
this methodology we also synthesized (E)-3-butylidene-
chroman-4-one 8g (R = Pr) (Table 1) starting from methyl
(2Z)-2-bromomethylhex-2-enoate 5g.¶
1 K. K. Purushothaman, K. Kalyani, K. Subramaniam and S. P.
Shanmughanathan, Indian J. Chem., Sect. B, 1982, 21, 383.
2 D. D. McPherson, G. A. Cordell, D. D. Soejarto, J. M. Pezzuto and
H. H. S. Fong, Phytochemistry, 1983, 22, 2835.
3 W. T. L. Sidwell and C. Tamm, Tetrahedron Lett., 1970, 475.
4 P. Bohler and C. Tamm, Tetrahedron Lett., 1967, 3479.
5 T. Al Nakib, V. Bezjak, M. J. Meegan and R. Chandy, Eur. J. Med.
Chem., 1990, 25, 455; Chem. Abstr., 1990, 113, 231160v.
6 W. Heller and C. Tamm, Progress in the chemistry of organic natural
products, ed. W. Herz, H. Grisebach and G. W. Kirby, Springer-Verlag,
New York, 1981, vol. 40, pp. 105–252.
The efficiency of this methodology has been demonstrated
via the synthesis of the methyl ether of bonducellin 13 and
(E)-3-(4-methoxybenzylidene)-6-methoxychroman-4-one 4, an
antifungal agent, according to Scheme 2.
7 S. Malhotra, V. K. Sharma and V. S. Parmar, J. Chem. Res. (S), 1988,
179.
In conclusion, we have developed a new protocol for the
synthesis of (E)-3-benzylidenechroman-4-ones involving the
initial synthesis of the benzylidene moiety, followed by
construction of the chroman-4-one system. Further application
of this methodology for the synthesis of biologically active
molecules is in progress in our laboratory.
We thank DST (New Delhi ) for funding this research project.
We thank UGC (New Delhi) for COSIST and the Special
Assistance Program at the School of Chemistry, University of
Hyderabad, Hyderabad. M. B. thanks UGC (New Delhi) and
S. P. thanks CSIR (New Delhi) for their research fellowships.
8 L. Farkas, A. Gottsegen and M. Nogradi, Tetrahedron, 1970, 26,
2787.
9 D. Basavaiah, P. D. Rao and R. S. Hyma, Tetrahedron, 1996, 52,
8001.
10 E. Ciganek, Org. React., 1997, 51, 201.
11 S. E. Drewes and G. H. P. Roos, Tetrahedron, 1988, 44, 4653.
12 A. Chamakh and H. Amri, Tetrahedron. Lett., 1998, 39, 375.
13 H. M. R. Hoffmann and J. Rabe, J. Org. Chem., 1985, 50, 3849.
14 D. Basavaiah and P. K. S. Sarma, J. Chem. Soc., Chem. Commun., 1992,
955.
15 D. Basavaiah, P. K. S. Sarma and A. K. D. Bhavani, J. Chem. Soc.,
Chem. Commun., 1994, 1091.
16 D. Basavaiah, S. Pandiaraju and P. K. S. Sarma, Tetrahedron. Lett.,
1994, 35, 4227.
17 D. Basavaiah, V. V. L. Gowriswari, P. K. S. Sarma and P. D. Rao,
Tetrahedron Lett., 1990, 31, 1621.
18 R. Buchholz and H. M. R. Hoffmann, Helv. Chim. Acta., 1991, 74,
1213.
19 O. Dann and H. Hofmann, Chem. Ber., 1962, 95, 1446.
20 L. M. Jackman and S. Sternhell, Applications of nuclear magnetic
resonance spectroscopy in organic chemistry, 2nd edn., Pergamon,
Oxford, 1969, vol. 5; S. W. Tobey, J. Org. Chem., 1969, 34, 1281.
21 A. Gruiec and A. Foucaud, New. J. Chem., 1991, 15, 943.
22 E. Ciganek, J. Org. Chem., 1995, 60, 4635; S. Wang, K. Yamamoto, H.
Yamada and T. Takahashi, Tetrahedron, 1992, 48, 2333.
23 M. Namikoshi, H. Nakata and T. Saitoh, Phytochemistry, 1987, 26,
1831.
Footnotes and References
† E-mail: dbsc@uohyd.ernet.in
‡ The (Z)-allyl bromides 5 were prepared from the corresponding
3-hydroxy-2-methylenealkanoates following the literature method (ref.
18).
OH
O
O
HBr, H2SO4
CH2Cl2
R
OMe
R
OMe
Br
§ Selected data for 8a: mp 110–111 °C (lit. 110–112 °C) (ref. 19);
nmax(KBr)/cm21 1668, 1601; dH(200 MHz, CDCl3) 5.35 (d, 2 H, J 1.6)
6.95–7.60 (m, 8 H), 7.88 (s, 1 H), 8.03 (d, 1 H, J 7.8); dC(50 MHz, CDCl3)
67.63, 117.93, 121.91, 122.06, 127.96, 128.74, 129.46, 129.99, 130.97,
Received in Cambridge, UK, 5th May 1998; revised manuscript received
22nd June 1998; 8/04796K
1640
Chem. Commun., 1998